Computational Drug Repurposing Across the Multiple Myeloma Spectrum: From MGUS to MM
Together, these results deliver a stage-specific, transparent resource for MM drug repurposing and combination design, intended to accelerate translation toward earlier disease intervention and improved patient outcomes.
Authors
- Jérôme Zoidakis (ORCID: https://orcid.org/0000-0002-4557-3430)
- Dimitris Stellas (ORCID: https://orcid.org/0000-0002-7787-3921)
- George M. Spyrou (ORCID: https://orcid.org/0000-0002-2470-3363)
- Kyriaki Savva (ORCID: https://orcid.org/0000-0002-0001-6593)
- Marilena M. Bourdakou (ORCID: https://orcid.org/0000-0001-8075-0634)
Institutions
- National and Kapodistrian University of Athens (GR)
- Academy of Athens (GR)
- Biomedical Research Foundation of the Academy of Athens (GR)
- National Hellenic Research Foundation (GR)
- Cyprus Institute of Neurology and Genetics (CY)
Publication Details
- Journal
- Cancers
- Published
- 2025-09-18
- DOI
- https://doi.org/10.3390/cancers17183045
- Citations
- 1
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- European Commission